First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

527 Reviews

Credit Rating - IS PHARMACEUTICALS LIMITED

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: IS PHARMACEUTICALS LIMITED, EDEN HOUSE LAKESIDE, CHESTER BUSINESS PARK, CHESTER, CH4 9QT. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 31 December 2022. The company was incorporated on 10 February 1992.

The accounts next due date is 30 September 2024. There are 10 mortgages, 10 satisfied, none part satisfied and none unsatisfied.

The above was based on public record information as at 23 October 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 02685820
Date Incorporated: 10 February 1992
Date Latest Accounts: 31 December 2022
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: MAELOR PHARMACEUTICALS LIMITED
Registered Number: 02685820
Annual Return: 21 January 2016
Registered Office: EDEN HOUSE LAKESIDE, CHESTER BUSINESS PARK, CHESTER, CH4 9QT
SIC Code and Operations: 99999
SECURED CREDITORS
Number of Mortgages 10
Satisfied Mortgages 10
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

IS PHARMACEUTICALS LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 2 November 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
12779385 IS PHOTOGRAPHY LTD Active - Proposal to Strike off
05614815 I'S PIES LIMITED Active
13814332 IS PLACES LIMITED Active
13252214 IS PORTFOLIO LIMITED Active
14002072 IS POTTER LTD Active

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd